Articles From: - Forest Laboratories, Inc. Announces Positive Topline Results from Three Phase III Trials for Vilazodone in the Treatment of Generalized Anxiety Disorder (GAD) to - Valeant Posts Fact-Based Answers To Refute Allergan's Misleading Statements


Forest Laboratories, Inc. (NYSE:FRX) today announced positive topline results from three Phase III trials evaluating the efficacy, safety and tolerability of vilazodone in adult patients with generalized anxiety disorder (GAD). In two flexible-dose and one fixed-dose GAD trials, patients who received vilazodone demonstrated statistically significant improvement from baseline in the Hamilton Rating Scale for Anxiety (HAM-A) total score versus placebo at week 8, the primary endpoint.
Sign-up for - Forest Laboratories, Inc. Announces Positive Topline Results from Three Phase III Trials for Vilazodone in the Treatment of Generalized Anxiety Disorder (GAD) investment picks
http://media.marketwire.com/attachments/201406/76593_range.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1125977&ProfileId=051205&sourceType=1 FORT WORTH, TX --
Sign-up for - Range Announces Conference Call to Discuss Second Quarter 2014 Financial Results investment picks
OVERLAND PARK, Kan., June 23, 2014 (GLOBE NEWSWIRE) -- YRC Worldwide Inc. (Nasdaq:YRCW) subsidiaries YRC Freight and Holland have joined the U.S. Chamber Foundation's Hiring Our Heroes program.
Sign-up for - YRC Freight and Holland Join "Hiring Our Heroes" Program investment picks
2014/6/23
Rigrodsky & Long, P.A.: Do you own shares of Measurement Specialties, Inc. (NASDAQ GS: MEAS )? Did you purchase any of your shares prior to June 18, 2014?
Sign-up for 2014/6/23 - MEASUREMENT SPECIALTIES, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout investment picks
LAS VEGAS, June 23, 2014 (GLOBE NEWSWIRE) -- Hemp, Inc.'s (OTC:HEMP) wholly owned subsidiary, The Industrial Hemp and Medical Marijuana Consulting Company, Inc. (IHMMCC), announced today that it has signed a consultant agreement with PPJ Enterprise (OTC:PPJE) , a leader in medical practice information management.
Sign-up for - PPJ Enterprise Triples Its Stock Price and Volume After Signing Agreement With Hemp, Inc.'s IHMMCC to Segue Into the Medical Marijuana Sector investment picks
2014/6/23
BOISE, Idaho, June 23, 2014 (GLOBE NEWSWIRE) -- Micron Technology, Inc .
Sign-up for 2014/6/23 - Micron Collaborates With Intel to Enhance Knights Landing With a High Performance, On-Package Memory Solution investment picks
B-2 program "family reunion" to feature re-enactment of first flight PALMDALE, Calif.
Sign-up for - Media Invited to Celebrate 25th Anniversary of B-2 Bomber First Flight investment picks
2014/6/23
Regional Network of the Year at Cannes Lions for DDB EMEA Canada NewsWire LONDON , June 23, 2014 /CNW/ - DDB EMEA was crowned Regional Network of the Year at the 2014 Cannes Lions Awards, which took place on Saturday, June 21 .
Sign-up for 2014/6/23 - Regional Network of the Year at Cannes Lions for DDB EMEA investment picks
Long-Acting VRS-317 Efficacy and Safety Comparable to Daily Growth Hormone Therapies CHICAGO, June 23, 2014 (GLOBE NEWSWIRE) -- Versartis, Inc. (Nasdaq:VSAR) , an endocrine-focused biopharmaceutical company that is developing a novel, long-acting form of recombinant human growth hormone (rhGH), today presented positive Phase 2a data from its six month clinical trial demonstrating the safety and efficacy of VRS-317 in the treatment of naïve, pre-pubertal children with growth hormone deficiency (GHD). These results are being presented by George Bright, MD, Versartis Vice President of Clinical Development, during the clinical poster session, "Growth and GH: Diagnostic Issues and Treatment" from 1:00 – 3:00 p.m. CDT today at the 16th International Congress of Endocrinology and The Endocrine Society's 96th Annual Meeting and Expo (ICE/ENDO 2014) in Chicago, IL.
Sign-up for - Versartis Presents Positive Six Month VRS-317 Phase 2a Clinical Study Results investment picks
DALLAS, June 23, 2014 (GLOBE NEWSWIRE) -- The Special Committee of SWK Holdings Corporation (OTCBB:SWKH) ("SWK" or the "Company"), a life science focused specialty finance company, today issued the following statement regarding Carlson Capital's letter to the Special Committee dated June 20, 2014: "In response to Carlson Capital's May 16, 2014 proposal to acquire 80 million shares of newly issued common stock of the Company at a price of $1.20 per share, the Special Committee has been considering a range of debt and equity financing alternatives with the objective of ensuring that the financing transaction ultimately pursued by the Company is in the best interests of all stockholders of the Company.
Sign-up for - SWK Holdings Corporation Special Committee Responds to Carlson Capital Letter investment picks
Intel Corporation announced that Aneel Bhusri, co-founder and chief executive officer of Workday, Inc. (NYSE: WDAY), has been elected to serve on the company’s board of directors.
Sign-up for - Aneel Bhusri Elected to Intel Board of Directors investment picks
2014/6/23
- Emerging markets remain winners of new global sovereign assets - despite overall underlying preferences, at a total portfolio level, for developed markets - Allocations to alternative investments increasing on a net respondent view basis - including real estate and private equity - Increase in new funding encourages global sovereigns to allocate assets strategically rather than tactically - Sovereign investor risk appetite and time horizons increasing, while home market bias decreasing - UK the most attractive international market to sovereign investors ATLANTA , June 23, 2014 /PRNewswire/ -- Invesco today released its second annual Invesco Global Sovereign Asset Management Study 1 , an in-depth report which offers insight into the complex investment behaviour of sovereign investors across the globe, and provides a framework to help understand the investment preferences of these funds.
Sign-up for 2014/6/23 - New Funding For Global Sovereigns Promotes Strategic Asset Allocation To Emerging Markets And Alternatives -Invesco Study investment picks
NEW YORK (MarketWatch) -- American Apparel's (APP) founder Dov Charney, who was suspended as president and chief executive last week and will be terminated after a 30-day cure period, said in a regulatory filing on Monday that "such termination is without merit" and that he "intends to contest it vigorously." Charney said since the board's announcement on June 18, he's been contacted by several unidentified supporters, including the company's shareholders, who wanted him to continue to lead the Los Angeles-based garment maker.
Sign-up for - American Apparel's founder Dov Charney is fighting back investment picks
NEW YORK (MarketWatch) -- FMC Corp.
Sign-up for - FMC shares slump 3% after profit warning investment picks
GARDEN CITY, N.Y. , June 23, 2014 /PRNewswire/ -- Millennium HealthCare Inc. (OTCBB: MHCC) through its wholly owned subsidiary, Millennium Medical Devices, LLC is assisting primary care physicians to offer their patients breakthrough diagnostics that are reimbursable by Medicare and private insurance companies.
Sign-up for - Millennium Healthcare Inc. Advances Patient Care With VasoScan Cardiovascular Assessment Test investment picks
2014/6/23
DENVER , June 23, 2014 /PRNewswire/ -- Farmland Partners Inc. (NYSEMKT: FPI) (the "Company") today announced that it has entered into a purchase agreement to acquire an approximately 1,250-acre row crop farm in Arkansas for approximately $4.6 million in cash.
Sign-up for 2014/6/23 - Farmland Partners Inc. Announces Agreement for Acquisition of Arkansas Farm investment picks
- Initiates Global Footprint, Diversifies Business, Enhances Long-term Growth Prospects - ANAHEIM, Calif.
Sign-up for - Questcor Pharmaceuticals Closes Transaction to Acquire International Rights to Synacthen® and Synacthen® Depot investment picks
Intercontinental Exchange (NYSE: ICE), the leading global network of exchanges and clearing houses, announced today that it has signed a definitive agreement with ULLINK, a provider of electronic trading and connectivity solutions to the financial community, for the combined sale of NYFIX and Metabit, both units of NYSE Technologies.
Sign-up for - Intercontinental Exchange Agrees to Sell NYFIX and Metabit to ULLINK investment picks
2014/6/23
During grand opening week, the Gourmet Burger Authority™ will donate all sales from its signature Freckled Lemonade® to Alex's Lemonade Stand Foundation GREENWOOD VILLAGE, Colo.
Sign-up for 2014/6/23 - Red Robin Gourmet Burgers is Two Weeks Away from Opening Its First Restaurant in Orlando, Florida investment picks
OSI Systems, Inc. (NASDAQ: OSIS) today announced that its Security division, Rapiscan Systems, has received a Foreign Military Sales (FMS) contract from the U.S. Department of Defense valued at approximately $102 million to supply multiple units of its cargo and vehicle inspection systems and related training, spare parts, service and logistics support for Iraq.
Sign-up for - OSI Systems Awarded $102 Million Contract from U.S. Department of Defense for Cargo and Vehicle Inspection Systems investment picks
2014/6/23
-- Sale closing still projected for second half of 2014 --
Sign-up for 2014/6/23 - OneBeacon Announces Progress Towards Sale Of Runoff Business investment picks
By Saumya Vaishampayan, MarketWatch NEW YORK (MarketWatch) -- Shares of Integrys Energy Group Inc. and Central Garden & Pet Co.
Sign-up for - Integrys Energy, Central Garden & Pet surge investment picks
2014/6/23
Company Updates Full Year Guidance for 2014 ANN ARBOR, Mich.
Sign-up for 2014/6/23 - Arotech Training And Simulation Division Receives $36M Follow-On Order For Its Virtual Clearance Training Suite Program investment picks
SAN RAMON, Calif., June 23, 2014 (GLOBE NEWSWIRE) -- On June 11, Five9 (Nasdaq:FIVN) announced the latest version of its cloud contact center software, introducing four new native multichannel applications (email, chat, social, and mobile) as well as an intelligent technology layer called Five9 Connect .
Sign-up for - Widespread Industry Praise for the Five9 Cloud Contact Center Software Summer Release 2014 investment picks
2014/6/23
SHANGHAI , June 23, 2014 /PRNewswire/ -- More than 400 life science innovators recently tuned in to a global webinar hosted by WuXi AppTec to gain insights into the advancement of programs that ultimately have been designated by the U.S. Food and Drug Administration as breakthrough therapies.
Sign-up for 2014/6/23 - WuXi AppTec Webinar on Breakthrough Drugs Draws Strong Attendance investment picks
LAVAL, Quebec , June 23, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that, as promised, it has posted fact-based answers to refute misleading assertions made by Allergan, Inc. (NYSE: AGN) in its June 10 th presentation.
Sign-up for - Valeant Posts Fact-Based Answers To Refute Allergan's Misleading Statements investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: - Forest Laboratories, Inc. Announces Positive Topline Results from Three Phase III Trials for Vilazodone in the Treatment of Generalized Anxiety Disorder (GAD) to - Valeant Posts Fact-Based Answers To Refute Allergan's Misleading Statements
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices